NANOG controls testicular germ cell tumour stemness through regulation of MIR9-2

Ryan P Cardenas,Ahmad Zyoud,Alan McIntyre,Ramiro Alberio,Nigel P Mongan,Cinzia Allegrucci

DOI: https://doi.org/10.1186/s13287-024-03724-1

2024-05-04

Stem Cell Research & Therapy

Abstract:Testicular germ cell tumours (TGCTs) represent a clinical challenge; they are most prevalent in young individuals and are triggered by molecular mechanisms that are not fully understood. The origin of TGCTs can be traced back to primordial germ cells that fail to mature during embryonic development. These cells express high levels of pluripotency factors, including the transcription factor NANOG which is highly expressed in TGCTs. Gain or amplification of the NANOG locus is common in advanced tumours, suggesting a key role for this master regulator of pluripotency in TGCT stemness and malignancy.

cell biology,medicine, research & experimental,cell & tissue engineering

What problem does this paper attempt to address?

This paper aims to address the molecular mechanisms in testicular germ cell tumors (TGCTs). Specifically, the study focuses on the following points:

1. **Unclear molecular mechanisms**: Although TGCTs are most common in young individuals and are sensitive to cisplatin chemotherapy, some patients do not respond to treatment, and the long-term side effects of chemotherapy significantly affect the quality of life of patients. Therefore, there is a need to develop more targeted therapies.

2. **Stem cell state and differentiation arrest**: TGCTs originate from primordial germ cells (PGCs) that fail to mature properly. These cells highly express pluripotency factors, such as the transcription factor NANOG. NANOG often shows gain or amplification in advanced tumors, suggesting its key role in maintaining TGCT stem cell characteristics and malignancy.

3. **miRNA regulatory network**: Through comprehensive bioinformatics analysis, the study identifies a set of miRNAs regulated by NANOG, particularly miR-9-2, which is found to be lowly expressed in TGCTs and associated with tumor progression. miR-9-2-5p is identified as a novel tumor suppressor, and its overexpression can reduce the proliferation and invasion of TGCT cells and increase sensitivity to cisplatin.

In summary, this paper focuses on revealing how NANOG controls TGCT stem cell characteristics by regulating miR-9-2-5p, providing new insights into the pathogenesis of TGCT and the development of new therapeutic strategies.